Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of altered methylation of MB-COMT promotor and DRD2 gene in cannabinoid or synthetic cannabinoid use disorder regarding gene variants and clinical parameters.

Journal of addictive diseases - 1 Jan 2000

Oyaci Yasemin, Aytac Hasan Mervan, Pasin Ozge, Cetinay Aydin Pinar, Pehlivan Sacide

Abstract excerpt

This study aims to investigate the association between cannabinoid use disorder (CUD) or synthetic cannabinoid use disorder (SCUD) and methylation status of MB-COMT (membrane-bound catechol-O-methyltransferase) promotor or DRD2 gene considering gene variants and clinical parameters. Based on the DSM-5 criteria, 218 CUD/SCUD patients' diagnoses were confirmed with a positive urine test, and a control group...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcohol Drinking
Share to Cannabinoids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Catechol O-Methyltransferase

Share to Genotype

Share to Polymorphism, Single Nucleotide

Share to Receptors, Dopamine D2

Share to Substance-Related Disorders

Source

Identifiers

PMID: 33781176
DOI: 10.1080/10550887.2021.1906618

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of altered methylation of MB-COMT promotor and DRD2 gene in cannabinoid or synthetic cannabinoid use disorder regarding gene variants and clinical parameters.PMID 33781176Read ↗

Global and glucocorticoid receptor gene-specific (NR3C1) DNA methylation analysis in patients with cannabinoid or synthetic cannabinoid use disorder.Semantic proximity Read ↗

Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients.Semantic proximity Read ↗

Association of single nucleotide polymorphism and methylation of dopamine system-related genes with psychotic symptoms in patients of methamphetamine use disordersSemantic proximity Read ↗

Catechol-O-methyltransferase gene methylation and substance use in adolescents: the TRAILS study.Semantic proximity Read ↗

Pathogenic study on catechol-O-methyltransferase gene and catecholaminergic neurotransmitters with attention deficit hyperactivity disorder in Chinese childrenSemantic proximity Read ↗

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.Semantic proximity Read ↗

A preliminary study on the association of single nucleotide polymorphisms and methylation of dopamine system-related genes with psychotic symptoms in patients with methamphetamine use disorder.Semantic proximity Read ↗

Gene variants and educational attainment in cannabis use: mediating role of DNA methylation.Semantic proximity Read ↗

The catechol-O-methyltransferase gene: its regulation and polymorphisms.Semantic proximity Read ↗

Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulatorSemantic proximity Read ↗

Contribution of Dopamine Transporter Gene Methylation Status to Cannabis DependencySemantic proximity Read ↗

In Silico Prediction of the Effects of Nonsynonymous Single Nucleotide Polymorphisms in the Human Catechol-O-Methyltransferase (COMT) Gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.